Lv42
610 积分 2022-02-15 加入
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
1天前
已完结
Tonic signaling in CAR-T therapy: the lever long enough to move the planet
1天前
已完结
Phase 1/2 Trial of Anti-CD7 Allogeneic WU-CART-007 in patients with Relapsed/Refractory T-cell Malignancies
1个月前
已完结
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors
2个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
4个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
4个月前
已完结
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
5个月前
已完结
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase
5个月前
已完结
Reprogramming site-specific retrotransposon activity to new DNA sites
5个月前
已完结
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
6个月前
已完结
皖公网安备34019202002308
